WO2009030056A1 - Capuchon protecteur pour aiguille - Google Patents

Capuchon protecteur pour aiguille Download PDF

Info

Publication number
WO2009030056A1
WO2009030056A1 PCT/CH2008/000362 CH2008000362W WO2009030056A1 WO 2009030056 A1 WO2009030056 A1 WO 2009030056A1 CH 2008000362 W CH2008000362 W CH 2008000362W WO 2009030056 A1 WO2009030056 A1 WO 2009030056A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
cap
injection
injection device
reactive substance
Prior art date
Application number
PCT/CH2008/000362
Other languages
German (de)
English (en)
Inventor
Benedikt Scheller
Original Assignee
Tecpharma Licensing Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecpharma Licensing Ag filed Critical Tecpharma Licensing Ag
Publication of WO2009030056A1 publication Critical patent/WO2009030056A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202Devices for protection of the needle before use, e.g. caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3146Priming, e.g. purging, reducing backlash or clearance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M2005/1401Functional features
    • A61M2005/1402Priming
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3125Details specific display means, e.g. to indicate dose setting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583Means for facilitating use, e.g. by people with impaired vision by visual feedback

Definitions

  • the invention relates to a needle cap.
  • the invention relates to a needle cap for an injection needle with a priming indicator disposed therein, wherein the priming indicator indicates a vented or a non-vented or an application ready or a non-ready operating state of an injection device.
  • the invention relates to an injection device with such a needle cap.
  • the injection device may be a simple syringe having a reservoir containing a fluid product or a syringe having a carpule prefilled with a fluid product.
  • the injection device can be releasably connected to a needle carrier, which has a firmly welded or glued injection needle.
  • the injection device can be firmly connected to a needle carrier, wherein the needle carrier has a firmly attached injection needle.
  • a packaged needle unit for an injection device which consists of three separate elements, namely an outer Nadelverpackungshülse, a needle cap and a needle carrier with a fixedly disposed injection needle.
  • these three elements are arranged one inside the other, so that the injection needle is enveloped by the needle cap and the needle cap is surrounded by the Nadelverpackungshülse.
  • the needle carrier is applied to an injection device and the needle packing sleeve and the needle protection cap can be removed.
  • WO 2005102419 A1 discloses an injection device for the administration of a fluid product from a prefilled carpule with priming function, preferably for medical, including veterinary, therapeutic, diagnostic, pharmaceutical and / or cosmetic applications. For these applications, it is important to administer a very specific fluid product dose. Since the cartridge of the injection device is not completely filled with the fluid product but contains air or other gas, without venting, the air or gas would be administered together with the fluid product. Consequently, none would correct product dose and health complications could occur. To ensure proper dosing, therefore, the air or gas that is in the carpule or accumulated during use must be removed.
  • a carpule plug may be provided in the carpule, wherein the carpule plug is movable in the axial feed direction to an outlet of the carpule in order to displace the fluid product from the carpule.
  • a flange fixedly connected to one end of a piston rod acts on the carpule plug.
  • product administration may reduce the administered product dose corresponding to this clearance. Consequently, no correct product dosage would be injected as well.
  • a functional check must be performed prior to product administration to ensure that the carpule plug is adjacent to the flange of the piston rod.
  • a priming dose which is preferably smaller than the active substance dose of the product to be injected, adjusted by means of a metering device and distributed by means of a dispensing device of the injection device.
  • the object of the invention is to provide a device which increases the safety due to the user friendliness, and that the priming process can be carried out properly before a targeted administration of the active substance.
  • a needle cap may have a sleeve-shaped base body, which may have a closed end, hereinafter referred to as the distal end, and an open end, hereinafter referred to as the proximal end.
  • the needle cap can be mounted on a needle carrier with a firmly connected injection needle so that the distal end of the needle cap surrounds the tip of the injection needle, the shell inner surface of the needle cap covers the shaft of the injection needle and the proximal end of the needle cap abuts the needle carrier.
  • the needle carrier may be a fixed component of a disposable needle unit, a disposable syringe or a disposable injection device.
  • an outer needle packing sleeve can be arranged around the needle protection cap and the needle carrier with the firmly attached injection needle.
  • This needle wrapping sleeve may also comprise a sleeve-shaped base body which may have a closed end, hereinafter referred to as a distal end, and an open end, hereinafter referred to as a proximal end.
  • the distal end of the needle wrapping sleeve may surround the distal end of the needle cap, the outer shell surface of the needle wrapping sleeve may encase the outer shell surface of the needle cap and the needle carrier with the fixed injection needle and optionally the syringe or injection device and the proximal end of the needle wrapping sleeve may be wrapped by a foil Closure or a cap-shaped lid be sealed sterile.
  • the needle protection cap according to the invention has on the inner surface, in particular on the inner surface of the distal end, on the shell inner surface of the sleeve-shaped base body and / or on the inner surface of the proximal end of the needle protection cap, a reactive substance, the change of a chemical, physical or physico-chemical State of the substance indicates, for example, by a visually recognizable aggregate change of the reactive substance, by a visually recognizable ion exchange reaction between the reactive substance and the fluid product or by a visually detectable catalytic reaction, wherein the reactive substance may be a catalyst.
  • the reactive substance can be connected directly or indirectly, for example by an adhesive, to the needle protection cap.
  • the reactive material may be an integral part of the needle guard.
  • at least part of the interior of the needle protection cap contains the reactive substance.
  • the needle cap according to the invention can enter into a releasable frictional, positive or other connection with the needle carrier, which has a firmly connected injection needle.
  • a priming dose can be set by means of a metering device of an injection device and this priming dose can be released by means of a dispensing device of the injection device.
  • the user especially in the use of a syringe, may depress product by feel through the hypodermic needle of the device without adjustment of a metering device.
  • the priming process is performed correctly if at least one drop of the fluid product is present at the hypodermic needle tip. This drop can wet the needle cap according to the invention.
  • the substance changes so that the user can visually recognize this change.
  • the reactive species can visually represent an enthalpy or entropy change of the reactive species.
  • the reactive species can be altered by an ion exchange reaction between the fluid product and the reactive to visually detect this change, with the reactive material having different anions or cations before wetting with the fluid product than after wetting with the fluid product.
  • the reactive substance may be an acid-base indicator.
  • a reactive substance is used for the needle cap, which discolors at the respective pH of the distributed product, for example, the pH indicator litmus at pH ⁇ 4.5 turns red and at pH> 8.3 blue.
  • the visual display can be used to verify that the priming process has been carried out correctly.
  • the needle protection cap can advantageously have a fluid-absorbing material, so that the drop that is released during the priming process is absorbed. Absorbing ensures that the consumer or the environment can not come into contact with the spilled fluid product, since the spilled droplets from the absorbing material is absorbed and can no longer flow out of the needle cap.
  • the reactive substance may be arranged between the inner surface of the needle protection cap, in particular the inner surface of the distal end, the inner shell surface of the sleeve-shaped base body and / or the inner surface of the proximal end of the needle protection cap, and the liquid-absorbent material such that, for example, a threshold of spilled product must first be absorbed by the absorbent material before the reactive can react with the spilled product to release a noticeable sign.
  • the liquid-absorbing material may be a granulate or powder coated with the reactive substance, or the reactive substance may be formed from a liquid-absorbing material.
  • the reactive material coated granules or powder or reactive material formed from a liquid absorbent material may be attached to the inner surface of the needle shield, in particular to the inner surface of the distal end, to the shell inner surface of the sleeve base body and / or to the inner surface be provided of the proximal end of the needle cap or be an integral part of the needle cap.
  • at least part of the interior of the needle protection cap can be filled with the reactive substance-coated granules or powder or the reactive substance which is formed from a liquid-absorbing material.
  • the reactive material coated granules or powder or reactive material formed from a liquid absorbent material may be directly or indirectly bonded to the needle shield, for example by an adhesive. It is advantageous that a chemical, physical or physico-chemical reaction of the reactive substance can take place with a smallest distributed product dose with delivery of a perceptible sign.
  • the liquid-absorbing material may be a natural or synthetic polymer, in particular cellulose or elastomer, for example polyurethane foam. This liquid-absorbing material may chemically combine or form a mixture with the reactive substance. Furthermore, between the reactive material or the liquid-absorbing material and the injection needle, a water-permeable material may be arranged so that no contamination of the injection needle with the reactive substance or the liquid-absorbing material takes place.
  • the water-permeable material may be a nonwoven fabric made, for example, based on a polypropylene-polyethylene blend, or a perforated film, such as a perforated polypropylene, polyester or polyethylene film.
  • the water-permeable material may also be made of cellulosic material.
  • Figure 1 A cross-sectional view of a needle unit with a needle cap and a packaging sleeve prior to priming.
  • Figure 2 A cross-sectional view of the needle unit with the needle cap after priming.
  • the needle unit consists of a needle carrier 7, which carries a firmly welded or glued injection needle 6.
  • the injection needle 6 is surrounded by the plugged onto the needle carrier 7 needle cap 2 and thus secured, so that the risk of accidental injury is reduced.
  • the needle cap 2 can be pushed, snapped or screwed onto the needle carrier 7.
  • the needle cap 2 is a detachable connection with the needle carrier 7 a.
  • the needle carrier 7 has a circumferential on an outer circumferential surface of the needle carrier 7 ring 7a, which protrudes in the distal direction and is arranged approximately parallel to the transverse axis of the needle carrier 7.
  • a bead 7b is provided which projects radially inward and extends in the circumferential direction of the ring 7a.
  • the bead 7b of the needle carrier 7 holds the needle cap 2 by the bead 7b of the needle carrier 7 is locked with a corresponding corresponding annular groove 2c of the needle cap 2.
  • the annular groove 2c is located on the outer circumferential surface of the needle cap 2 and extends approximately parallel to the transverse axis of the needle cap 2.
  • Needle cap 2 In a base body of Needle cap 2 is further provided at least one circular opening 2d, in this embodiment, two circular openings 2d are present.
  • the needle packing sleeve 1 is plugged or screwed onto the needle protection cap 2 in order to pack the needle unit with the needle protection cap 2 in a sterile manner and to protect it from impacts or from external forces.
  • the proximal end of the packaging sleeve 1 is closed with a film 8.
  • the needle protection cap according to the invention has an interior which is partly filled with cellulose granules 3.
  • the filled with cellulose granules interior is limited by the distal end of the needle cap and at least through a part of the sleeve-shaped base body and by a part of a non-woven, in particular a polypropylene-polyethylene nonwoven.
  • the cellulose granules are aggregated so that there is a gap 9 between the cellulose aggregate and the polypropylene polyethylene nonwoven.
  • the polypropylene-polyethylene nonwoven fabric 5 is arranged to the transverse axis of the needle cap 2 and covers the tip of the injection needle 3 and at least part of the shaft of the injection needle 6.
  • the polypropylene polyethylene non-woven 5 is shaped so that it is not in contact with the tip and the shaft of the injection needle 6 comes.
  • the polypropylene-polyethylene nonwoven 5 is mixed with a fixing agent in order to increase the dimensional stability.
  • the cellulose granules 3 are designed to absorb liquid.
  • the cellulose granules 3 are coated with a pH-sensitive substance 4, in particular with a pH indicator such as litmus.
  • FIG. 2 shows a cross-sectional view of the needle unit with the needle protection cap 2 after priming.
  • a fluid product such as insulin at pH 4
  • the foil 8 is withdrawn from the needle wrap sleeve 1 and the needle carrier 7, which has the firmly bonded injection needle 6, with the needle guard 2 and the needle wrap sleeve 1 mounted on the injection device, plugged, clamped, snapped or screwed.
  • On the outer circumferential surface of the needle packing sleeve 1 are projections or grooves, which protrude radially outwardly, provided, which facilitate the attachment of the needle carrier 7 to the injection device. After attaching the needle carrier to the injection device, the needle wrapping sleeve 1 is pulled away from the needle unit.
  • the priming is performed by setting a priming dose by means of a metering device of the injection device and distributed by means of a dispensing device of the injection device.
  • the priming dose of insulin is thereby injected into the needle cap 2.
  • the insulin permeates the polypropylene-polyethylene nonwoven 5 and is absorbed by the litmus cellulose aggregates contained in the needle cap 2, so that the insulin no longer flows out of the needle cap 2.
  • the air or the gas, which is located in the interior of the needle cap 2 can escape through the openings 2 d of the base body of the needle cap 2 b.
  • the acidic insulin enters into a protolysis equilibrium with the litmus cellulose granules.
  • the initially colorless insulin takes on the color red of Lackmus yarn.
  • the red color indicates that the priming process was performed properly.
  • the red colored needle cap 2 can be removed or removed from the needle carrier 7 and the product dose can be administered,

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La présente invention concerne un capuchon protecteur pour une aiguille d'injection, lequel capuchon comprend une substance réactive qui indique la variation d'un état chimique, physique ou physicochimique de la substance.
PCT/CH2008/000362 2007-09-04 2008-09-02 Capuchon protecteur pour aiguille WO2009030056A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH13732007 2007-09-04
CH1373/07 2007-09-04

Publications (1)

Publication Number Publication Date
WO2009030056A1 true WO2009030056A1 (fr) 2009-03-12

Family

ID=40085485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2008/000362 WO2009030056A1 (fr) 2007-09-04 2008-09-02 Capuchon protecteur pour aiguille

Country Status (1)

Country Link
WO (1) WO2009030056A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030602A1 (fr) * 2008-09-09 2010-03-18 Baxter International Inc. Dispositif pour indiquer l’amorçage d’une ligne de perfusion
US8632503B2 (en) 2008-03-13 2014-01-21 Becton, Dickinson And Company Safety pen needle assembly having shielding for patient and non-patient ends
US8801673B2 (en) 2008-03-13 2014-08-12 Becton Dickinson & Company Safety pen needle assembly having shield for non-patient end
US9623194B2 (en) 2013-12-10 2017-04-18 Becton, Dickinson And Company Passive safety pen needle assembly
US9642971B2 (en) 2008-03-13 2017-05-09 Becton, Dickinson And Company Safety needle assembly
US9649452B2 (en) 2013-12-10 2017-05-16 Becton, Dickinson And Company Active safety pen needle assembly

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187403A1 (en) * 2002-03-30 2003-10-02 Ernest Balestracci Tamper evident overap for a container
US20050283116A1 (en) * 2001-01-12 2005-12-22 Bracco Diagnostics Inc. Tamper evident syringe barrel
US20070287989A1 (en) * 2006-05-08 2007-12-13 Becton, Dickinson & Company Vascular access device pathogenic status indication
US20080021392A1 (en) * 2006-07-20 2008-01-24 Lurvey Kent L Medical fluid access site with antiseptic indicator
EP1547630B1 (fr) * 2003-12-23 2008-04-23 JMS North America Corp. Protection à double membrane pour un transducteur

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050283116A1 (en) * 2001-01-12 2005-12-22 Bracco Diagnostics Inc. Tamper evident syringe barrel
US20030187403A1 (en) * 2002-03-30 2003-10-02 Ernest Balestracci Tamper evident overap for a container
EP1547630B1 (fr) * 2003-12-23 2008-04-23 JMS North America Corp. Protection à double membrane pour un transducteur
US20070287989A1 (en) * 2006-05-08 2007-12-13 Becton, Dickinson & Company Vascular access device pathogenic status indication
US20080021392A1 (en) * 2006-07-20 2008-01-24 Lurvey Kent L Medical fluid access site with antiseptic indicator

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8632503B2 (en) 2008-03-13 2014-01-21 Becton, Dickinson And Company Safety pen needle assembly having shielding for patient and non-patient ends
US8801673B2 (en) 2008-03-13 2014-08-12 Becton Dickinson & Company Safety pen needle assembly having shield for non-patient end
US9162030B2 (en) 2008-03-13 2015-10-20 Becton, Dickinson And Company Safety pen needle assembly having shielding for patient and non-patient ends
US9642971B2 (en) 2008-03-13 2017-05-09 Becton, Dickinson And Company Safety needle assembly
US10322250B2 (en) 2008-03-13 2019-06-18 Becton, Dickinson And Company Safety needle assembly
US10398858B2 (en) 2008-03-13 2019-09-03 Becton, Dickinson And Company Safety needle assembly
WO2010030602A1 (fr) * 2008-09-09 2010-03-18 Baxter International Inc. Dispositif pour indiquer l’amorçage d’une ligne de perfusion
US8398590B2 (en) 2008-09-09 2013-03-19 Baxter International Inc. Device to indicate priming of an infusion line
US8663160B2 (en) 2008-09-09 2014-03-04 Baxter International Inc. Device to indicate priming of an infusion line
US9623194B2 (en) 2013-12-10 2017-04-18 Becton, Dickinson And Company Passive safety pen needle assembly
US9649452B2 (en) 2013-12-10 2017-05-16 Becton, Dickinson And Company Active safety pen needle assembly

Similar Documents

Publication Publication Date Title
WO2009030056A1 (fr) Capuchon protecteur pour aiguille
DE60315006T2 (de) Vorrichtung zum mischen von medizinischen flüssigkeiten
DE69926106T2 (de) Stiftnadelmagazin
DE60037531T2 (de) Medikamentenkartusche und injektionsvorrichtung
EP2300079B1 (fr) Ampoule avec support d' ampoule
DE60315003T2 (de) Flüssigkeitstransfer-anordnung
DE69726530T2 (de) Abdichtende Schutzbarriere für eine Spritze
EP1557189B1 (fr) Appareil d'injection
DE69819254T2 (de) Behälter mit einem Luer-Filter zur Verabreichung eines Arzneistoffes
DE19856167C1 (de) Nadelschutzanordnung für Spritzen, Karpulen und dergleichen Injektionsinstrumente
EP1186312B1 (fr) Dispositif distributeur de substances
DE19705189A1 (de) Verkaufseinheit für die parenterale Applikation, Vorrichtung zur Durchführung der parenteralen Applikation sowie Nachfülleinheit für die zuvor genannte Verkaufseinheit
DE60006047T2 (de) Ampulle zur aufnahme einer medizinischen flüssigkeit
EP2588221B1 (fr) Dispositif combiné de mélange et de déversement
CH696186A5 (de) Vorrichtung zur Sicherung von Injektionsnadeln.
CH433605A (de) Einrichtung zum Mischen von zwei Stoffen und zum Füllen einer Spritze mit der Mischung
EP2893946A1 (fr) Bouchon pour seringue de poudre et seringue de poudre
WO2013117332A1 (fr) Dispositif d'injection
DE102005043805A1 (de) Zentrierhilfe zum Aufsetzen einer Nadel auf ein Injektionsgerät
WO2010140063A2 (fr) Dispositif d'administration de médicaments fluides
AT504766B1 (de) Einweg-injektionsgerät
WO2009089638A1 (fr) Unité d'aiguille comportant un manchon disposé entre un porte-aiguille et un manchon d'emballage d'aiguille
DE2844206C2 (de) Schutzkappe
WO2020249738A2 (fr) Système de transfert de liquide et composants dédiés
DE60224940T2 (de) Sicherheitsverpackung für eine flasche für medizinische anwendungen

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08783462

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08783462

Country of ref document: EP

Kind code of ref document: A1